Works by Decker, Thomas

Results: 193
    1

    Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.

    Published in:
    European Radiology, 2023, v. 33, n. 2, p. 1174, doi. 10.1007/s00330-022-09053-2
    By:
    • Hofmann, Felix O.;
    • Heinemann, Volker;
    • D'Anastasi, Melvin;
    • Gesenhues, Alena B.;
    • Hesse, Nina;
    • von Weikersthal, Ludwig Fischer;
    • Decker, Thomas;
    • Kiani, Alexander;
    • Moehler, Markus;
    • Kaiser, Florian;
    • Heintges, Tobias;
    • Kahl, Christoph;
    • Kullmann, Frank;
    • Scheithauer, Werner;
    • Link, Hartmut;
    • Modest, Dominik P.;
    • Stintzing, Sebastian;
    • Holch, Julian W.
    Publication type:
    Article
    2
    3

    SPOP targets the immune transcription factor IRF1 for proteasomal degradation.

    Published in:
    eLife, 2023, p. 1, doi. 10.7554/eLife.89951
    By:
    • Schwartz, Irene;
    • Vunjak, Milica;
    • Budroni, Valentina;
    • Cantoran García, Adriana;
    • Mastrovito, Marialaura;
    • Soderholm, Adrian;
    • Hinterndorfer, Matthias;
    • de Almeida, Melanie;
    • Hacker, Kathrin;
    • Jingkui Wang;
    • Froussios, Kimon;
    • Jude, Julian;
    • Decker, Thomas;
    • Zuber, Johannes;
    • Versteeg, Gijs A.
    Publication type:
    Article
    4
    5

    Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions.

    Published in:
    Cellular & Molecular Life Sciences, 2025, v. 82, n. 1, p. 1, doi. 10.1007/s00018-025-05625-9
    By:
    • Karjalainen, Anzhelika;
    • Witalisz-Siepracka, Agnieszka;
    • Prchal-Murphy, Michaela;
    • Martin, David;
    • Sternberg, Felix;
    • Krunic, Milica;
    • Dolezal, Marlies;
    • Fortelny, Nikolaus;
    • Farlik, Matthias;
    • Macho-Maschler, Sabine;
    • Lassnig, Caroline;
    • Meissl, Katrin;
    • Amenitsch, Lena;
    • Lederer, Therese;
    • Pohl, Elena;
    • Gotthardt, Dagmar;
    • Bock, Christoph;
    • Decker, Thomas;
    • Strobl, Birgit;
    • Müller, Mathias
    Publication type:
    Article
    6

    FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.

    Published in:
    2021
    By:
    • Heinemann, Volker;
    • von Weikersthal, Ludwig Fischer;
    • Decker, Thomas;
    • Kiani, Alexander;
    • Kaiser, Florian;
    • Al-Batran, Salah-Edin;
    • Heintges, Tobias;
    • Lerchenmüller, Christoph;
    • Kahl, Christoph;
    • Seipelt, Gernot;
    • Kullmann, Frank;
    • Moehler, Markus;
    • Scheithauer, Werner;
    • Held, Swantje;
    • Miller-Phillips, Lisa;
    • Modest, Dominik Paul;
    • Jung, Andreas;
    • Kirchner, Thomas;
    • Stintzing, Sebastian
    Publication type:
    journal article
    7
    8
    9
    10
    11
    12
    13

    Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER<sup>+</sup> breast cancer.

    Published in:
    BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03671-x
    By:
    • Zimmer, Philipp;
    • Esser, Tobias;
    • Lueftner, Diana;
    • Schuetz, Florian;
    • Baumann, Freerk T.;
    • Rody, Achim;
    • Schneeweiss, Andreas;
    • Hartkopf, Andreas D.;
    • Decker, Thomas;
    • Uleer, Christoph;
    • Stoetzer, Oliver J.;
    • Foerster, Frank;
    • Schmidt, Marcus;
    • Mundhenke, Christoph;
    • Steindorf, Karen;
    • Tesch, Hans;
    • Jackisch, Christian;
    • Fischer, Thomas;
    • Hanson, Sven;
    • Kreuzeder, Julia
    Publication type:
    Article
    14
    15

    Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.

    Published in:
    Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
    By:
    • Oudard, Stephane;
    • Benhamouda, Nadine;
    • Escudier, Bernard;
    • Ravel, Patrice;
    • Tran, Thi;
    • Levionnois, Emeline;
    • Negrier, Sylvie;
    • Barthelemy, Philippe;
    • Berdah, Jean François;
    • Gross-Goupil, Marine;
    • Sternberg, Cora N.;
    • Bono, Petri;
    • Porta, Camillo;
    • Giorgi, Ugo De;
    • Parikh, Omi;
    • Hawkins, Robert;
    • Highley, Martin;
    • Wilke, Jochen;
    • Decker, Thomas;
    • Tanchot, Corinne
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

    Published in:
    Breast Care, 2024, v. 19, n. 1, p. 49, doi. 10.1159/000535135
    By:
    • Decker, Thomas;
    • Zaiss, Matthias;
    • Klein, Dunja;
    • Hahn, Antje;
    • Hagen, Volker;
    • La Rosée, Paul;
    • Liersch, Rüdiger;
    • Wolff, Thomas;
    • Niemeier, Beate;
    • Hillebrand, Larissa E.;
    • Lennartz, Carolin;
    • Chiabudini, Marco;
    • Bengsch, Fee;
    • Indorf, Martin;
    • Marschner, Norbert
    Publication type:
    Article
    24

    The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11046-3
    By:
    • Martens, Uwe M.;
    • Schröder, Jan;
    • Bengsch, Fee;
    • Sellmann, Ludger;
    • Busies, Sabine;
    • Frank-Gleich, Stefanie;
    • Zaiss, Matthias;
    • Decker, Thomas;
    • Schneeweiss, Andreas;
    • Schuler, Martin;
    • Grebhardt, Sina;
    • Zacharias, Stefan;
    • Marschner, Norbert;
    • Kasenda, Benjamin;
    • Potthoff, Karin;
    • Vannier, Corinne
    Publication type:
    Article
    25

    The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4<sup>+</sup> T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.

    Published in:
    Molecular & Cellular Biology, 2021, v. 41, n. 9, p. 1, doi. 10.1128/MCB.00085-21
    By:
    • Arnett, Azlann;
    • Moo, Keagan G.;
    • Flynn, Kaitlin J.;
    • Sundberg, Thomas B.;
    • Johannessen, Liv;
    • Shamji, Alykhan F.;
    • Gray, Nathanael S.;
    • Decker, Thomas;
    • Ye Zheng;
    • Gersuk, Vivian H.;
    • Rahman, Ziaur S.;
    • Levy, David E.;
    • Marié, Isabelle J.;
    • Linsley, Peter S.;
    • Xavier, Ramnik J.;
    • Khor, Bernard
    Publication type:
    Article
    26

    Sepsis:avoiding its deadly toll.

    Published in:
    Journal of Clinical Investigation, 2004, v. 113, n. 10, p. 1387, doi. 10.1172/JCI200421819
    By:
    • Decker, Thomas
    Publication type:
    Article
    27
    28

    Breast carcinomas of low malignant potential.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 1, p. 5, doi. 10.1007/s00428-021-03163-w
    By:
    • Schnitt, Stuart J.;
    • Fend, Falko;
    • Decker, Thomas
    Publication type:
    Article
    29
    30

    Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.

    Published in:
    HemaSphere, 2022, v. 6, n. 6, p. e729, doi. 10.1097/HS9.0000000000000729
    By:
    • Kutsch, Nadine;
    • Pallasch, Christian;
    • Decker, Thomas;
    • Hebart, Holger;
    • Chow, Kai Uwe;
    • Graeven, Ullrich;
    • Kisro, Jens;
    • Kroeber, Alexander;
    • Tausch, Eugen;
    • Fischer, Kirsten;
    • Fink, Anna‐Maria;
    • Wendtner, Clemens‐Martin;
    • Ritgen, Matthias;
    • Stilgenbauer, Stephan;
    • Zhang, Danjie;
    • Li, Biao;
    • Jürgensmeier, Juliane M.;
    • Rajakumaraswamy, Nishanthan;
    • Bhargava, Pankaj;
    • Hallek, Michael
    Publication type:
    Article
    31
    32
    33

    Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 478, doi. 10.1080/10428194.2022.2148210
    By:
    • Kutsch, Nadine;
    • Holmes, Emily Eva;
    • Robrecht, Sandra;
    • Schüler, Gudrun;
    • Vehling-Kaiser, Ursula;
    • Decker, Thomas;
    • Müller-Hagen, Sigrun;
    • Heinisch, Karin;
    • Böttcher, Sebastian;
    • Ritgen, Matthias;
    • Kreuzer, Karl-Anton;
    • Stilgenbauer, Stephan;
    • Fink, Anna Maria;
    • Fischer, Kirsten;
    • Eichhorst, Barbara;
    • Hallek, Michael;
    • Wendtner, Clemens-Martin
    Publication type:
    Article
    34
    35
    36
    37
    38

    Mycobacteria-induced granuloma necrosis depends on IRF-1.

    Published in:
    Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 8b, p. 2069, doi. 10.1111/j.1582-4934.2008.00470.x
    By:
    • Aly, Sahar;
    • Mages, Jörg;
    • Reiling, Norbert;
    • Kalinke, Ulrich;
    • Decker, Thomas;
    • Lang, Roland;
    • Ehlers, Stefan
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

    Published in:
    Pathology & Oncology Research, 2007, v. 13, n. 1, p. 5, doi. 10.1007/BF02893435
    By:
    • Cserni, Gábor;
    • Bianchi, Simonetta;
    • Vezzosi, Vania;
    • Arisio, Riccardo;
    • Bori, Rita;
    • Peterse, Johannes;
    • Sapino, Anna;
    • Castellano, Isabella;
    • Drijkoningen, Maria;
    • Kulka, Janina;
    • Eusebi, Vincenzo;
    • Foschini, Maria;
    • Bellocq, Jean-Pierre;
    • Marin, Cristi;
    • Thorstenson, Sten;
    • Amendoeira, Isabel;
    • Reiner-Concin, Angelika;
    • Decker, Thomas;
    • Lacerda, Manuela;
    • Figueiredo, Paulo
    Publication type:
    Article
    48
    49
    50